A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902) Meeting Abstract

  

Authors:	Grilley-Olson, J. E.; Allred, J. B.; Schuetze, S.; Davis, E. J.; Wagner, M. J.; Poklepovic, A. S.; Waechter, B.; Riedel, R. F.; Welliver, M. X.; Berg, S. A.; George, S.; Robinson, S. I.; Googe, P. B.; D'Angelo, S. P.; Schwartz, G. K.
Abstract Title:	A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902)
Meeting Title:	2023 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	41
Issue:	16 Suppl.
Meeting Dates:	2023 Jun 2-6
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2023-06-01
Language:	English
DOI:	10.1200/JCO.2023.41.16_suppl.11503
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=164013106&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting abstract: 11503 -- Meeting also presented virtually -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/209563